Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BAL PHARMA LTD. - 524824 - Intimation On Receipt Of NCLT Order.

 We wish to inform that the Company has received order dated 24th August 2023 from Hon''ble National Company Law Tribunal , Bangalore bench ( NCLT) and received by us on 30.08.2023, directing the Company to convene meetings of equity shareholders, Secured and Unsecured creditors of the Company on Tuesday October 3 ,2023 , for the purpose of considering and if thought fit approving the proposed scheme of merger of Golden Drugs Pvt Ltd with Bal Pharma Ltd, its holding Company. The said order of NCLT is enclosed herewith and has also been made available on the Company''s website i.e www.balpharma.com.
31-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Reg. 34 (1) Annual Report.

 As already informed to the exchanges, 36th Annual General Meeting of the Shareholders of the Company is scheduled to be held on 25th September 2023 at 10.30 A.M through audio visual means. Notice along with the details of the business to be transacted at the meeting and Audited financial statements of the Company for the F.Y ended 31.03.2023 together with the reports of Directors and auditors there on is being dispatched to our shareholders in electronic form. A Copy of the unabridged annual report of the Company for the financial year ended 31.03.2023 is enclosed for submission to the exchanges. Annual report for F.Y 2022.23 is also available on our website i.e www.balpharma/ar.com.
30-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Notice Of The 36Th Annual General Meeting Of The Company

 We are submitting to the exchange Notice of the 36th Annual General Meeting of the Company scheduled to be held on 25.09.2023 i.e on Monday at 10.30 A.M through AV/OAVM. Voting rights of the members is in proportion to their shareholding in the Company as on the cutoff date i.e 18th September 2023.
25-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Change in Management

 We would like to inform the exchanges that Ms.Nicola Neeladri ( DIN # 01997936 ) is appointed as Independent Director of the Company for a second term of 5 years i.e up to 22nd August 2028 w.e.f 23rd August 2023 and whose office shall not be liable to retire by rotation. Shareholders of the Company by a special resolution passed through postal ballot has approved the appointment of Ms.Nicola Neeladri ( DIN # 01997936 ) as Independent Director of the Company, with requisite majority. Voting result of the postal ballot along with the scrutinizers report was already submitted to the exchanges vide our intimation dated 23.08.2023 and also uploaded on our website i.e www.balpharma.com
24-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 We are submitting to the exchanges , e-voting results of the postal ballot along with the scrutinizers report. The resolution proposed has been passed with requisite majority through postal ballot. Please take this intimation on record.
23-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We are submitting to the exchange newspaper advertisements of abridged Unaudited standalone and Consolidated financial results of the Company for the quarter ended 30.06.2023 announced by the Company on 11.08.2023 and published in Financial Express ( English) and Sanjayvani ( Kannada) , on 12.08.2023.
14-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Book Closure Intimation

 We would like to inform the exchanges that the Register of Members and Share transfer books of the Company will remain closed from 19th September 2023 to 25th September 2023 ( Both days inclusive ) to ascertain the entitlement of Dividend and for the 36th Annual General meeting scheduled to be held on 25.09.2023.
11-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Intimation Regarding Book Closure

 We would like to inform the exchanges that the Register of Members and Share Transfer books of the Company will remain closed from 19th September 2023 to 25th September 2023 ( both days inclusive ) to ascertain the entitlement of dividend and for the 36th Annual General Meeting of the Company scheduled to be held on 25.09.2023 i.e on Monday.
11-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting

 Board of Directors of the Company has met today and inter alia transacted the following business. 1.Taken on record and approved the Un-audited standalone and consolidated financial results of the Company for the quarter ended 30.06.2023. A copy of the approved financial results together with the limited review report issued by the statutory auditors of the Company with unmodified opinion is enclosed with this intimation. 2. Decided to convene 36th Annual General Meeting of the Company on 25th September 2023 i.e on Monday at 10:30 A.M, through audio visual means. 3. Decided to close the Register of Members and Share transfer books of the Company from 19.09.2023 to 25.09.2023 (both days inclusive) to ascertain the entitlement of Dividend and for the 36th Annual General Meeting of the Company. The meeting commenced at 4.30 p.m. and concluded at 5:40 p.m on Friday, 11th August 2023.
11-08-2023
Bigul

BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30.06.2023.

 BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve 1.Un-Audited Standalone and Consolidated financial results of the Company for the quarter ended 30.06.2023. 2.To convene the 36th Annual General Meeting of the Company. 3. To decide on the Book closure dates. 4. Other AGM related matters.
01-08-2023
Next Page
Close

Let's Open Free Demat Account